Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Langerhans cell histiocytosis: progress and controversies.

Abla O, Rollins B, Ladisch S.

Br J Haematol. 2019 Jul 15. doi: 10.1111/bjh.16099. [Epub ahead of print] No abstract available.

PMID:
31309539
2.

Pediatric Langerhans cell histiocytosis: state of the science and future directions.

Thacker NH, Abla O.

Clin Adv Hematol Oncol. 2019 Feb;17(2):122-131. Review.

PMID:
30845115
3.

Impact of Videotaped Information on the Experience of Parents of Children with Acute Lymphoblastic Leukemia.

Di Giuseppe G, Pole JD, Abla O, Punnett A.

J Cancer Educ. 2019 Feb 9. doi: 10.1007/s13187-019-1485-2. [Epub ahead of print]

PMID:
30739269
4.

A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.

Chellapandian D, Hines MR, Zhang R, Jeng M, van den Bos C, Santa-María López V, Lehmberg K, Sieni E, Wang Y, Nakano T, Williams JA, Fustino NJ, Astigarraga I, Dunkel IJ, Abla O, van Halteren AGS, Pei D, Cheng C, Weitzman S, Sung L, Nichols KE.

Cancer. 2019 Mar 15;125(6):963-971. doi: 10.1002/cncr.31893. Epub 2018 Dec 6.

PMID:
30521100
5.

Usability Testing of an Interactive Virtual Reality Distraction Intervention to Reduce Procedural Pain in Children and Adolescents With Cancer [Formula: see text].

Birnie KA, Kulandaivelu Y, Jibb L, Hroch P, Positano K, Robertson S, Campbell F, Abla O, Stinson J.

J Pediatr Oncol Nurs. 2018 Nov/Dec;35(6):406-416. doi: 10.1177/1043454218782138. Epub 2018 Jun 27.

PMID:
29950139
6.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL.

Blood. 2018 Jun 28;131(26):2877-2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2. Review.

7.

Outcome and Toxicity Patterns in Children and Adolescents with Non-Hodgkin Lymphoma: A Single Institution Experience.

Angelini P, Rodriguez L, Zolaly M, Naqvi A, Weitzman S, Abla O, Punnett A.

Mediterr J Hematol Infect Dis. 2018 Mar 1;10(1):e2018020. doi: 10.4084/MJHID.2018.020. eCollection 2018.

8.

Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma.

Langenberg-Ververgaert KPS, Laxer RM, Punnett AS, Dupuis LL, Finkelstein Y, Abla O.

Mediterr J Hematol Infect Dis. 2018 Mar 1;10(1):e2018019. doi: 10.4084/MJHID.2018.019. eCollection 2018.

9.

Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.

Ronceray L, Abla O, Barzilai-Birenboim S, Bomken S, Chiang AK, Jazbec J, Kabickova E, Lazic J, Beishuizen A, Mellgren K, Tanaka F, Pillon M, Devalck C, Gouttenoire M, Makarova O, Burkhardt B, Attarbaschi A; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26932. Epub 2017 Dec 29.

PMID:
29286565
10.

Finding active LCH cells in the blood.

Abla O.

Blood. 2017 Oct 26;130(17):1874-1875. doi: 10.1182/blood-2017-09-805424. No abstract available.

PMID:
29074592
11.

Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.

Messinger Y, Boklan J, Goldberg J, DuBois SG, Oesterheld J, Abla O, Martin A, Weinstein J, Hijiya N.

Pediatr Hematol Oncol. 2017 May;34(4):187-198. doi: 10.1080/08880018.2017.1360970. Epub 2017 Oct 17.

PMID:
29039989
12.

Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL; North American Consortium for Histiocytosis.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26784. Epub 2017 Sep 25. Review.

PMID:
28944988
13.

Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.

Abla O, Ribeiro RC, Testi AM, Montesinos P, Creutzig U, Sung L, Di Giuseppe G, Stephens D, Feusner JH, Powell BL, Hasle H, Kaspers GJL, Dalla-Pozza L, Lassaletta A, Tallman MS, Locatelli F, Reinhardt D, Lo-Coco F, Hitzler J, Sanz MA.

Ann Hematol. 2017 Sep;96(9):1449-1456. doi: 10.1007/s00277-017-3042-6. Epub 2017 Jun 8.

PMID:
28597167
14.

Management of primary central nervous system lymphoma in children.

Giulino-Roth L, Abla O, Batchelor TT.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):386-389. Review.

15.

Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.

Abla O, Kutny MA, Testi AM, Feusner JH, Creutzig U, Gregory J Jr, Gibson B, Leverger G, Ribeiro RC, Smith O, Locatelli F, Kaspers G.

Br J Haematol. 2016 Nov;175(4):588-601. doi: 10.1111/bjh.14313. Epub 2016 Sep 21. No abstract available.

PMID:
27651168
16.

Underlying undiagnosed inherited marrow failure syndromes among children with cancer.

Alabbas F, Weitzman S, Grant R, Bouffet E, Malkin D, Abla O, Dror Y.

Pediatr Blood Cancer. 2017 Feb;64(2):302-305. doi: 10.1002/pbc.26120. Epub 2016 Aug 31.

PMID:
27577695
17.

Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.

Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group.

Haematologica. 2016 Dec;101(12):1581-1591. Epub 2016 Aug 11.

18.

Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.

Chellapandian D, Makras P, Kaltsas G, van den Bos C, Naccache L, Rampal R, Carret AS, Weitzman S, Egeler RM, Abla O.

Mediterr J Hematol Infect Dis. 2016 Jul 1;8(1):e2016033. doi: 10.4084/MJHID.2016.033. eCollection 2016.

19.

Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.

Shago M, Abla O, Hitzler J, Weitzman S, Abdelhaleem M.

Pediatr Blood Cancer. 2016 Nov;63(11):1915-21. doi: 10.1002/pbc.26116. Epub 2016 Jul 8.

PMID:
27392123
20.

Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases.

Mellgren K, Attarbaschi A, Abla O, Alexander S, Bomken S, Bubanska E, Chiang A, Csóka M, Fedorova A, Kabickova E, Kapuscinska-Kemblowska L, Kobayashi R, Krenova Z, Meyer-Wentrup F, Miakova N, Pillon M, Plat G, Uyttebroeck A, Williams D, Wróbel G, Kontny U; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the international Berlin-Frankfurt-Münster (i-BFM) Group.

Ann Hematol. 2016 Aug;95(8):1295-305. doi: 10.1007/s00277-016-2722-y. Epub 2016 Jun 7.

PMID:
27270301
21.

Primary Cutaneous Lymphomas in Children and Adolescents.

Ceppi F, Pope E, Ngan B, Abla O.

Pediatr Blood Cancer. 2016 Nov;63(11):1886-94. doi: 10.1002/pbc.26076. Epub 2016 May 27. Review.

PMID:
27229270
22.

Primary Effusion Lymphoma (PEL)-Like Lymphoma in a Child With Congenital Immunodeficiency.

Lam GK, Abdelhaleem M, Somers GR, Roifman C, Read S, Abla O.

Pediatr Blood Cancer. 2016 Sep;63(9):1674-6. doi: 10.1002/pbc.26069. Epub 2016 May 17.

PMID:
27186682
23.

Adolescent and young adult non-Hodgkin lymphoma.

Hochberg J, El-Mallawany NK, Abla O.

Br J Haematol. 2016 May;173(4):637-50. doi: 10.1111/bjh.14074. Epub 2016 Apr 12. Review.

PMID:
27071675
24.

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society.

Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10. Review.

25.

Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study.

Ceppi F, Weitzman S, Woessmann W, Davies K, Lassaletta A, Reismüller B, Mellgren K, Uyttebroeck A, Maia I, Abdullah S, Miakova N, Glaser D, Cohn R, Abla O, Attarbaschi A, Alexander S.

Am J Hematol. 2016 May;91(5):486-91. doi: 10.1002/ajh.24329. Epub 2016 Apr 4.

26.

Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.

Abla O, Angelini P, Di Giuseppe G, Kanani MF, Lau W, Hitzler J, Sung L, Naqvi A.

J Pediatr Hematol Oncol. 2016 Mar;38(2):111-7. doi: 10.1097/MPH.0000000000000490.

PMID:
26794706
27.

Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.

Haroche J, Abla O.

Hematology Am Soc Hematol Educ Program. 2015;2015:571-8. doi: 10.1182/asheducation-2015.1.571.

PMID:
26637774
28.

Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition.

Abla O, Weitzman S.

Hematology Am Soc Hematol Educ Program. 2015;2015:565-70. doi: 10.1182/asheducation-2015.1.565.

PMID:
26637773
29.

Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.

Inaba H, Zhou Y, Abla O, Adachi S, Auvrignon A, Beverloo HB, de Bont E, Chang TT, Creutzig U, Dworzak M, Elitzur S, Fynn A, Forestier E, Hasle H, Liang DC, Lee V, Locatelli F, Masetti R, De Moerloose B, Reinhardt D, Rodriguez L, Van Roy N, Shen S, Taga T, Tomizawa D, Yeoh AE, Zimmermann M, Raimondi SC.

Blood. 2015 Sep 24;126(13):1575-84. doi: 10.1182/blood-2015-02-629204. Epub 2015 Jul 27.

30.

Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.

Chellapandian D, Shaikh F, van den Bos C, Somers GR, Astigarraga I, Jubran R, Degar B, Carret AS, Mandel K, Belletrutti M, Dix D, Visser J, Abuhadra N, Chang T, Rollins B, Whitlock J, Weitzman S, Abla O.

Pediatr Blood Cancer. 2015 Dec;62(12):2162-6. doi: 10.1002/pbc.25645. Epub 2015 Jul 14.

PMID:
26179251
31.

Treatment of young children with CNS-positive acute lymphoblastic leukemia without cranial radiotherapy.

Wilejto M, Di Giuseppe G, Hitzler J, Gupta S, Abla O.

Pediatr Blood Cancer. 2015 Nov;62(11):1881-5. doi: 10.1002/pbc.25620. Epub 2015 Jul 7.

PMID:
26154757
32.

A Multicenter Experience from Lebanon in Childhood and Adolescent Acute Myeloid Leukemia: High rate of Early Death in Childhood Acute Promyelocytic Leukemia.

Farah RA, Horkos JG, Bustros YD, Farhat HZ, Abla O.

Mediterr J Hematol Infect Dis. 2015 Jan 1;7(1):e2015012. doi: 10.4084/MJHID.2015.012. eCollection 2015.

33.

Paediatric acute lymphoblastic leukaemia mimicking Langerhans cell histiocytosis of bone.

Abla O, Stimec J, Abdelhaleem M, Howard A.

Br J Haematol. 2015 Mar;168(6):770. doi: 10.1111/bjh.13263. Epub 2014 Dec 18. No abstract available.

PMID:
25521432
34.

Writing guidelines without a net: ECD.

Abla O, Arceci R.

Blood. 2014 Jul 24;124(4):472-4. doi: 10.1182/blood-2014-06-578997. No abstract available.

35.

Updates on histiocytic disorders.

Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O.

Pediatr Blood Cancer. 2014 Jul;61(7):1329-35. doi: 10.1002/pbc.25017. Epub 2014 Mar 9.

PMID:
24610771
36.

How I treat children and adolescents with acute promyelocytic leukaemia.

Abla O, Ribeiro RC.

Br J Haematol. 2014 Jan;164(1):24-38. doi: 10.1111/bjh.12584. Epub 2013 Sep 30. Review.

37.

Human metapneumovirus (hMPV) infection in children with cancer.

Ali M, Baker JM, Richardson SE, Weitzman S, Allen U, Abla O.

J Pediatr Hematol Oncol. 2013 Aug;35(6):444-6. doi: 10.1097/MPH.0b013e31828ac89c.

PMID:
23588336
38.

Central nervous system juvenile xanthogranuloma after langerhans cell histiocytosis.

Abla O, Halliday W, Laughlin S, Weitzman S.

Pediatr Blood Cancer. 2013 Feb;60(2):342-3. doi: 10.1002/pbc.24379. Epub 2012 Oct 25. No abstract available.

PMID:
23109301
39.

Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girl.

Naithani R, Ngan BY, Roifman C, Crump M, Baruchel S, Abla O.

J Pediatr Hematol Oncol. 2012 Oct;34(7):552-5.

PMID:
22469942
40.

Association between obesity at diagnosis and weight change during induction and survival in pediatric acute lymphoblastic leukemia.

Ethier MC, Alexander S, Abla O, Green G, Lam R, Sung L.

Leuk Lymphoma. 2012 Sep;53(9):1677-81. doi: 10.3109/10428194.2012.664843. Epub 2012 Mar 26.

PMID:
22390648
41.

Reversal of LCH-related diabetes insipidus and reappearance of posterior pituitary bright spot with low-dose chemotherapy.

Abla O, Palmert MR.

Pediatr Blood Cancer. 2012 Jul 15;59(1):201-2. doi: 10.1002/pbc.24061. Epub 2012 Jan 4. No abstract available.

PMID:
22223352
42.

Langerhans cell histiocytosis and Erdheim-Chester disease.

Wilejto M, Abla O.

Curr Opin Rheumatol. 2012 Jan;24(1):90-6. doi: 10.1097/BOR.0b013e32834db53e. Review.

PMID:
22157416
43.

Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Abla O, Weitzman S, Blay JY, O'Neill BP, Abrey LE, Neuwelt E, Doolittle ND, Baehring J, Pradhan K, Martin SE, Guerrera M, Shah S, Ghesquieres H, Silver M, Betensky RA, Batchelor T.

Clin Cancer Res. 2011 Jan 15;17(2):346-52. doi: 10.1158/1078-0432.CCR-10-1161. Epub 2011 Jan 11.

44.

Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia.

Junqueira BL, Connolly B, Abla O, Tomlinson G, Amaral JG.

Cancer. 2010 Sep 15;116(18):4368-75. doi: 10.1002/cncr.25286.

45.

Hodgkin lymphoma presenting with hair graying.

Trakymiene SS, Abla O.

J Pediatr Hematol Oncol. 2010 Jul;32(5):417-8. doi: 10.1097/MPH.0b013e3181df6172. No abstract available.

PMID:
20502355
46.

Langerhans cell histiocytosis: Current concepts and treatments.

Abla O, Egeler RM, Weitzman S.

Cancer Treat Rev. 2010 Jun;36(4):354-9. doi: 10.1016/j.ctrv.2010.02.012. Epub 2010 Feb 25. Review.

PMID:
20188480
47.

Evaluating the ability to detect change of health-related quality of life in children with Hodgkin disease.

Klaassen RJ, Krahn M, Gaboury I, Hughes J, Anderson R, Grundy P, Ali SK, Jardine L, Abla O, Silva M, Barnard D, Cappelli M.

Cancer. 2010 Mar 15;116(6):1608-14. doi: 10.1002/cncr.24883.

48.

Nurses provide valuable proxy assessment of the health-related quality of life of children with Hodgkin disease.

Klaassen RJ, Barr RD, Hughes J, Rogers P, Anderson R, Grundy P, Ali SK, Yanofsky R, Abla O, Silva M, Carret AS, Cappelli M.

Cancer. 2010 Mar 15;116(6):1602-7. doi: 10.1002/cncr.24888.

49.

Hepatitis-associated aplastic anemia presenting as a familial bone marrow failure syndrome.

Breakey VR, Meyn S, Ng V, Allen C, Dokal I, Lansdorp PM, Abla O, Dror Y.

J Pediatr Hematol Oncol. 2009 Nov;31(11):884-7. doi: 10.1097/MPH.0b013e3181b86ec3.

PMID:
19779378
50.

Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.

Afzal S, Ethier MC, Dupuis LL, Tang L, Punnett AS, Richardson SE, Allen U, Abla O, Sung L.

Pediatr Infect Dis J. 2009 Dec;28(12):1064-8. doi: 10.1097/INF.0b013e3181aa6eae.

PMID:
19773675

Supplemental Content

Support Center